Recommendation ID
DG15/1
Question
NICE recommends that robust evidence be generated to show the clinical effectiveness of the AccuTnI+3 assay for the early rule out of non-ST-segment elevation myocardial infarction (NSTEMI) in people presenting to an emergency department with acute chest pain.Where possible the accuracy of the AccuTnI+3 assay and its resulting clinical outcomes should be compared with both high-sensitivity troponin assays recommended in section 1.1 of the guidance (DG15) and standard troponin assays.
Any explanatory notes
(if applicable)
None.

Source guidance details

Comes from guidance
Myocardial infarction (acute): Early rule out using high-sensitivity troponin tests (Elecsys Troponin T high-sensitive, ARCHITECT STAT High Sensitive Troponin-I and AccuTnI+3 assays)
Number
DG15
Date issued
October 2014

Other details

Is this a recommendation for the use of a technology only in the context of research? No  
Is it a recommendation that suggests collection of data or the establishment of a register?   No  
Last Reviewed 27/11/2014